Arrhythmia, Diabetes Mellitus, Type 1
Conditions
Keywords
Type 1 diabetes, Cardiovascular disease, Hypoglycaemia, Exercise-related hypoglycaemia
Brief summary
Patients with type 1 diabetes are recommended to perform at least 150 minutes of accumulated physical activity each week, however fear of hypoglycaemia is a well-known barrier to exercise in these patients. Previous experimental studies have almost exclusively focused on investigating cardiovascular effects of hypoglycaemia under resting conditions, however other underlying circumstances prior to or during a hypoglycaemic event, (e.g. exercise) are rarely discussed in the literature but might, nevertheless, be of significant clinical importance. In this study, the investigators aim to investigate the QT interval dynamics and prothrombotic factors during exercise-related hypoglycaemia in comparison with hypoglycaemia under resting conditions, in patients with type 1 diabetes. Fifteen patients with type 1 diabetes will be recruited for a crossover study including two test days, a combined euglycaemic- hypoglycaemic clamp combined with an exercise session and an euglycaemic- hypoglycaemic clamp during bed rest, respectively. Furthermore, the participants will be schedueled for a 24-hours followup visit after each test day for the purpose of investigating prolonged prothrombotic effects of hypoglycaemia. Patients will be randomised 1:1 to start with the combined exercise-clamp or the resting-clamp. The two test days will be separated by at least 4 weeks to minimise carry-over effects. A group of fifteen healthy individuals with normal glucose tolerance matched for age, gender and body mass index, will be recruited for a single blood test aiming to compare baseline coagulation status with patients with type 1 diabetes.
Interventions
OTHERExercise-related hypoglycaemia
Hypoglycaemia induced by intravenous insulin and exercise on a vertical cycle ergometer.
OTHERHypoglycaemia under resting conditions
Hypoglycaemia induced by intravenous insulin during bed rest.
Sponsors
Steno Diabetes Center Copenhagen
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Informed and written consent * Type 1 diabetes diagnosed according to the criteria of the World Health Organization (WHO) * Age ≥ 18 years * Insulin treatment for ≥1 year
Exclusion criteria
* Arrhythmia diagnosed prior to the screening visit. * Ischaemic heart disease or myocardial infarction diagnosed prior to the screening visit. * Implantable cardioverter defibrillator (ICD) or pacemaker at the time of inclusion * Heart failure (left ventricular ejection fraction \<45%) diagnosed prior to the screening visit. * Structural heart disease (Wolf-Parkinson-White syndrome, congenital heart disease, severe valve disease) * ECG with left or right bundle branch block diagnosed prior to the screening visit. * Thyroid dysfunction (except for well-regulated levothyroxine-substituted myxoedema) * Anaemia (male: haemoglobin \<8.0; female: haemoglobin \<7.0 mmol/l) * Treatment with anticoagulant or antiplatelet treatment. * Bleeding disorder diagnosed prior to the screening visit. Withdrawal criteria \- The participants may withdraw at will at any time
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hypoglycaemia and QTc interval prolongation | 0-180minutes | Mean QTc interval prolongation from baseline during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hypoglycaemia and QT dispersion (QTd) | 0-180minutes | Differences in QTd, during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions |
| Hypoglycaemia and heart rate variability (HRV) | 0-180minutes | Changes in sympathetic/parasympathetic balance (measured by HRV) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and bradycardia | 0-180minutes | Differences in non-clinically significant bradycardia (≤45 bpm for 5 seconds) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and ectopic beats | 0-180minutes | Differences in number of atrial ectopic beats (prematurity threshold 30%) and ventricular premature beats respectively, during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and endothelial activation and damage | 0-24hours | Differences in plasma markers of endothelial activation and damage (ng/ml) (including Syndecan-1, Soluble thrombomodulin and PECAM-1) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and vascular oxidative stress | 0-24hours | Differences in markers of vascular oxidative stress (tetrahydrobiopterin/dihydrobiopterin ratio, dehydroascorbic acid/ascorbic acid ratio, asymmetric dimethylarginine/arginine ratio, malondialdehyde) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Key secondary outcome: Hypoglycaemia and coagulation and fibrinolysis | 0-24hours | Differences in whole blood coagulability and fibrinolysis (measured by thrombelastography) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and counterregulatory hormonal response | 0-180minutes | Differences in hormonal response (plasma glucagon, cortisol, catecholamines and growth hormone) during exercise-related hypoglycaemia compared insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and markers of inflammation | 0-24hours | Differences in inflammatory response (including interleukin 6 and TNFα) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and inflammation | 0-24hours | Differences in High-sensitive C-reactive peptide (HsCRP) during exercise-related hypoglycaemia compared to insulin-induced hypoglycaemia under resting conditions. |
| Hypoglycaemia and continuous glucose monitoring (CGM) accuracy | 0-180min | Differences in mean absolute relative difference (MARD) between Dexcom G6®, Abbot Flash Libre® and Yellow Springs Instrument (YSI) reference throughout both experimental days. |
| Type 1 diabetes, healthy controls and coagulability | 0minutes | Differences in whole blood coagulability and fibrinolysis (measured by thrombelastography) between patients with type 1 diabetes and healthy control subjects. |
| Hypoglycaemia and electrolytes | 0-180minutes | Differences in electrolyte concentrations including potassium and ionised calcium during exercise-related hypoglycaemia compared insulin-induced hypoglycaemia under resting conditions. |
Countries
Denmark
Outcome results
None listed